People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Pharma, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ADvantage Therapeutics, Inc. | — | Pharma | Series A | $19.0M | $111.4M | 2021 |
| Klothea Bio, Inc. | — | Biotech / Pharma | Seed | $2.9M | $12.1M | 2024 |
Jeffrey B. Madden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey B. Madden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Walter B. Schmidt | 2 | 2 |
| Olivier B. Jarry | 1 | 1 |
| Agustin B. Fernandez Santana III | 1 | 1 |
| Agustin Fernandez Santana III | 1 | 1 |
| David B. Buchsbaum | 1 | 1 |
| Frank B. Mattner | 1 | 1 |
| Petr B. Sramek | 1 | 1 |
| James B. O'Neill | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.